Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01578993 · ClinicalTrials.gov registry record
Observational Study of Complications Related to Use of Peripherally Inserted Central Catheters
A clinical trial, sponsored by Teleflex.
- Completed
- Registry status
- 101
- Enrollment target
NCT01578993: Completed study, sponsored by Teleflex.
NCT01578993 is a clinical trial that has completed, run by Teleflex. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01578993 has completed, sponsored by Teleflex.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the rate and timing of interventions and complications related to the use of peripherally inserted central venous catheters in adult patients.
Primary Outcome
The incidence, severity and management of PICC line occlusions were recorded for each of the enrolled subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-10 |
What the finished NCT01578993 record still lists
NCT01578993 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01578993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01578993 about?
NCT01578993 is a clinical study titled "Observational Study of Complications Related to Use of Peripherally Inserted Central Catheters". The purpose of this study is to determine the rate and timing of interventions and complications related to the use of peripherally inserted central venous catheters in adult patients.
What is the current status of trial NCT01578993?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2012-08. Estimated completion is 2013-10.
Who is sponsoring clinical trial NCT01578993?
This trial is sponsored by Teleflex, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia